DISORDER
MECHANISM
LABS · FEATURES
CLUE · TREATMENT
Primary hyperparathyroidism
Adenoma (~85%), hyperplasia (MEN1, MEN2A), carcinoma
↑ Ca²⁺, ↓ PO₄³⁻, ↑ PTH, ↑ ALP, ↑ urine Ca²⁺ and cAMP; often found on routine labs
Parathyroidectomy · cinacalcet if not a surgical candidate
Hyperparathyroidism — features
Bone resorption + hypercalcemia effects
Kidney stones, polyuria; osteitis fibrosa cystica (subperiosteal resorption of phalanges, brown tumors, salt-and-pepper skull); constipation, pancreatitis, PUD; depression, fatigue
"Stones, bones, groans, thrones, psychiatric overtones"
Familial hypocalciuric hypercalcemia
Loss-of-function CaSR (AD) → higher calcium set point
Mild ↑ Ca²⁺, normal/mildly ↑ PTH, ↓ urine Ca²⁺ (Ca/Cr clearance < 0.01)
Benign — no surgery
Humoral hypercalcemia of malignancy
PTHrP acts on PTH receptor
↑ Ca²⁺, ↓ PO₄³⁻, ↓ PTH; squamous cell lung, head and neck, RCC, bladder, breast, ovary
Most common cause in inpatients
Calcitriol-mediated hypercalcemia
Macrophage 1α-hydroxylase (PTH-independent)
Lymphoma, sarcoidosis, TB, other granulomas; ↑ calcitriol, ↓ PTH
Glucocorticoids
Tumor → RANKL, IL-6 → osteoclasts
Breast cancer metastases, multiple myeloma; ↓ PTH
Bisphosphonates, denosumab
Excess intake, ↓ excretion, ↑ turnover
Vitamin D toxicity, milk-alkali syndrome, thiazides, lithium, immobilization, hyperthyroidism, adrenal insufficiency
Acute: IV saline, calcitonin, bisphosphonate
Thyroid/neck surgery (most), autoimmune (APS-1, AIRE), DiGeorge (22q11), infiltration, hypomagnesemia
↓ Ca²⁺, ↑ PO₄³⁻, ↓ PTH; tetany, perioral numbness, Chvostek and Trousseau signs, long QT, seizures
Calcium + calcitriol; replace Mg²⁺ first
Pseudohypoparathyroidism 1A
GNAS (Gsα) mutation inherited from mother → kidney/bone resistance to PTH
↓ Ca²⁺, ↑ PO₄³⁻, ↑ PTH; Albright hereditary osteodystrophy: short stature, short 4th/5th metacarpals, round face, obesity
Pseudo-pseudo: paternal GNAS, AHO with normal labs
↓ gut Ca²⁺ absorption → secondary ↑ PTH → phosphate wasting
Low/normal Ca²⁺, ↓ PO₄³⁻, ↑ PTH, ↑ ALP; rickets/osteomalacia
CKD-related HPT: see
12.10
Malignant chief cells; CDC73 (HRPT2)
Very high Ca²⁺ (> 14), palpable neck mass, severe bone and kidney disease
En bloc resection